PRF1 and neoplasm: Firstly, IL-12 can activate T cells and NK cells to drive Th1 differentiation of CD4+ T cells via enhanced production of IFN-γ and augments the cytolytic ability of NK and CD8+ T cells towards tumor cells via granzyme B and perforin secretion1.